The invention relates generally to diagnostic medical devices and specifically to devices for detecting anemia.
This application claims priority to and the benefit of provisional application Ser. No. 62/322,890, filed on Apr. 15, 2016, which is herein incorporated in its entirety by reference.
Radio frequency identification (RFID) has recently seen use in applications that streamline logistics and reduce medical errors in the healthcare industry. RFID systems are capable of wirelessly interrogating and extracting ID from tags deployed on physical assets in the hospital setting. RFID systems afford automated, non line-of-sight object identification at large scale and are currently being used to track expensive equipment, monitor patient and staff motion and ensure correct drug distribution.
Recently there have been attempts to use RFID tags for applications beyond object identification, such as pervasive sensing. RFID tags have been used in several applications ranging from implants to DNA characterization and enzyme detection. Where cost is a driving factor, designs making use of passive RFID tags are particularly appealing. The advent of paper-based analytical devices presents several opportunities in passive RFID based-sensing.
Paper-based analytical devices (μ-PADs) are devices consisting of channels created by patterning paper with hydrophobic materials. Biological and chemical reagents are then added to the channels to create different tests. While many of these tests have a colorimetric readout and are read by eye, novel methods for data acquisition and management are needed to maintain assay objectivity, increase sensitivity and obtain quantitative measurements. There is also a need to automate the process of output readout and scale the functionality to multiple tests running in parallel.
Hematocrit is defined as the percentage of red blood cells (RBCs) by volume in the blood and can range from 20% to 60%. Normal values of hematocrit vary according to a person's age, sex, pregnancy status and altitude. Healthy adult males typically have a hematocrit ranging from 42% to 54%. Healthy adult females have a hematocrit ranging from 38% to 46%, and normal babies and children may range from 29% to 68%. Hematocrit values below these normal values for the specified population may indicate that the individual is suffering from anemia. Hence, an assay to rapidly screen for anemia should differentiate hematocrit values between 20% and 40%, while producing a stable signal for hematocrits levels above 50%.
The assay for measurement of the hematocrit percentage in whole blood is based on the principal that, in a porous structure, plasma will separate more slowly from blood samples with higher hematocrits. This is thought to occur because red blood cells, when placed on a porous membrane, are pulled into pores by capillary force and become entrapped if the pore size is smaller than the diameter of the cell. As more blood cells become trapped, they block some of the pores, reducing the open area for plasma to filter through the membrane and thus, reducing the plasma flow speed in the membrane.
The present invention relates to an RFID-based anemia detection sensor designed by coupling a μ-PAD device, seeded with a fixed volume of a patient's blood, with an RFID tag. Differences in red blood corpuscle concentration in the blood manifest themselves as controlled changes in the RFID tag backscatter signal response. By observing these changes at the RFID reader, it is possible to discriminate between the blood of a healthy and anemic patient.
In one aspect, the invention relates to a method of measuring hematocrit. In one embodiment, the method includes the steps of providing an assay device including an RFID tag; a micro-PAD defining a sample port and a channel, the micro-PAD in electrical communication with the RFID tag; measuring, using an RFID reader the change of impedance of the RFID tag over time; and determining the hematocrit of the sample in response to the time change of impedance.
In another aspect the invention relates to a system for measuring the hematocrit of a sample. In one embodiment, the system includes an assay device including: an RFID tag;
a micro-PAD defining a sample port and a channel, the micro-PAD in electrical communication with the RFID tag; and an RFID reader, wherein the RFID reader measures the change of impedance of the RFID tag over time; and determines the hematocrit of the sample in response to the time change of impedance.
Yet another aspect the invention relates to a wireless blood anomaly detection system. In one embodiment, the system includes: an RFID tag including an RFID chip and an RFID antenna; and a blood probe including: a substrate defining a port in fluid communication with a channel, the channel including a metallic strip and a ground plane, wherein the metallic strip is in electrical communication with the RFID antenna, wherein the port is configured to accept a blood sample, and wherein the channel has an impedance which changes as the blood sample moves from the port and through the channel, and an RFID reader generating a carrier signal and configured to monitor the change in back scatter signal of the carrier signal, as reflected back by the RFID tag, as blood moves down the channel.
In another embodiment, the RFID reader measures the time it takes for blood to move down the channel in response to a change in back scatter frequency and generates a hematocrit value in response to the time of blood movement. In yet another embodiment, the RFID reader measures the time it takes for blood to move down the channel in response to a change in signal strength and generates an hematocrit value in response to the time of blood movement.
Still yet another aspect of the invention relates to a wireless blood anomaly detection sensor. In one embodiment, the sensor includes an RFID tag comprising an RFID chip and an RFID antenna; and a blood probe comprising: a substrate defining a port in fluid communication with a channel, the channel including a metallic strip and a ground plane, wherein the metallic strip is in electrical communication with the RFID antenna, wherein the port is configured to accept a blood sample, and wherein the channel has an impedance which changes as the blood moves from the port and through the channel
Another aspect of the invention relates to a method for blood anomaly detection. In one embodiment, the method includes the steps of providing an RFID tag comprising an RFID chip and an RFID antenna; and a blood probe. In another embodiment, the blood probe includes: a substrate defining a port in fluid communication with a channel, the channel including a metallic strip and a ground plane, wherein the metallic strip is in electrical communication with the RFID antenna, wherein the port is configured to accept a blood sample, and wherein the channel has an impedance which changes as the blood sample moves from the port and through the channel; generating a carrier signal with an RFID reader; and monitoring with the RFID reader, the change in back scatter of the carrier signal as blood moves down the channel.
In yet another embodiment, the backscatter measurement includes measuring a change in signal strength. In still yet another embodiment, the backscatter measurement includes measuring a change in the frequency response of the RFID tag received by the RFID reader.
Yet another aspect of the invention relates to a wireless fluid component detection system. In one embodiment, the system includes: an RFID tag comprising an RFID chip and an RFID antenna; and a fluid probe including: a substrate defining a port in fluid communication with a channel, the channel including a metallic strip and a ground plane, wherein the metallic strip is in electrical communication with the RFID antenna, wherein the port is configured to accept a fluid sample, and wherein the channel has an impedance which changes as the fluid sample moves from the port and through the channel, and an RFID reader generating a carrier signal and configured to monitor the change in back scatter signal of the carrier signal, as reflected back by the RFID tag, as fluid moves down the channel.
In another embodiment, the RFID reader measures the time it takes for a fluid sample to move down the channel in response to a change in RFID tag back scatter frequency and generates a component concentration value in response to the time of fluid movement. In yet another embodiment, the RFID reader measures the time it takes for a fluid sample to move down the channel in response to a change in signal strength and generates a component concentration value in response to the time of fluid movement.
Still yet another aspect of the invention relates to a method for fluid component detection. In one embodiment, the method includes the steps of providing an RFID tag comprising an RFID chip and an RFID antenna; and a fluid probe. In another embodiment, the fluid probe includes: a substrate defining a port in fluid communication with a channel, the channel including a metallic strip and a ground plane, wherein the metallic strip is in electrical communication with the RFID antenna, wherein the port is configured to accept a fluid sample, and wherein the channel has an impedance which changes as the fluid sample moves from the port and through the channel; generating a carrier signal with an RFID reader; and monitoring with the RFID reader, the change in back scatter of the carrier signal as fluid moves down the channel.
In another embodiment, the backscatter measurement comprises measuring a change in signal strength. In yet another embodiment, the backscatter measurement comprises measuring a shift or change in the frequency response of the RFID tag received by the RFID reader.
Another aspect of the invention relates to a wireless fluid component detection sensor. In one embodiment, the sensor includes an RFID tag comprising an RFID chip and an RFID antenna; and a fluid probe including: a substrate defining a port in fluid communication with a channel, the channel including a metallic strip and a ground plane, wherein the metallic strip is in electrical communication with the RFID antenna, wherein the port is configured to accept a fluid sample, and wherein the channel has an impedance which changes as the fluid moves from the port and through the channel.
The structure and function of the invention can be best understood from the description herein in conjunction with the accompanying figures. The figures are not necessarily to scale, emphasis instead generally being placed upon illustrative principles. The figures are to be considered illustrative in all aspects and are not intended to limit the invention, the scope of which is defined only by the claims.
The last decade has seen several advances in novel low-cost, RFID-based sensing. Researchers have achieved this either by interfacing the RFID's tag IC with sensor electronics or by using the tag's antenna as a sensor. The latter approach often uses electromagnetically responsive smart materials or background changes to an RFID tag to cause a controlled change in tag signal parameters, such as backscatter signal strength or response frequency. There have been several case studies where researchers have developed RFID devices to sense parameters like temperature alarms, humidity, volatile organics, and pH.
Researchers have even used RFID tag-sensors in several bio-medical applications. For instance, one design uses implantable RFID tags in body sensors. Another design uses an RFID tag as a wireless front end in a DNA sequence characterization device. In this design, different DNA sequences cause different changes in light intensity that can be detected by a photo-sensor. The photo-sensor data is then conveyed wirelessly to an RFID reader by interfacing the sensor with an RFID tag. Fluorescence intensity in chemiluminescent immunoassays for detecting thyroid-stimulating hormones have also utilized RFID sensors.
Paper-based analytical devices (μ-PADs) are being developed for a wide range of functions, from rapid point-of-care measurement of liver enzyme levels to routine measurement of heavy metal contamination in reservoir water. One recently created μ-PAD measured femtomolar quantities of an enzyme based upon flow time. In this assay, an area of hydrophobic polymer was applied to both an experimental and control channel, initially retarding flow. If a blood sample contained a certain enzyme, hydrogen peroxide produced in the experimental channel switched the hydrophobic polymer to a hydrophilic polymer, allowing fluid to flow through the channel more rapidly. As the fluid reached the end of each channel, it picked up dried green dye in the channel and appeared as a green circle on top of the assay. The time difference for fluid to flow through the experimental channel versus the control channel was calculated using visual interpretation of the appearance of the green dye circles and a timer. This time difference directly correlated to the original enzyme concentration. While the concept of a timing assay demonstrates promise—having a high sensitivity and tolerance to volume, temperature and humidity changes—the assay requires the user to continually monitor the experimental and control areas for color change, recording the time taken for each event.
To overcome the issues of the monitoring of the timing assay and to scale the functionality to multiple tests running in parallel, the present invention relates to an RFID tag-sensor that can remotely monitor the flow of microliter volumes of fluid in paper membranes. As fluid flows down a channel it selectively detunes the RFID tag sensor. This manifests itself as a sharp, predictable drop in the strength of the backscatter signal from the RFID tag. By wirelessly monitoring the time at which the signal drops, remotely monitoring of paper-based timing assays is accomplished.
To demonstrate the efficacy of the flow sensing RFID tag for a paper-based timing assay the present invention uses a timing assay to screen for anemia based on hematocrit levels in whole blood. According to the World Health Organization, anemia afflicts 47% of preschool-age children and 41% of pregnant women worldwide, impairing cognitive and physical development. Anemia, which is characterized by a reduced ability of the circulatory system to transport oxygen through the body, is clinically defined by either a low hematocrit or a low hemoglobin level. As the hematocrit percentage directly affects the ability of paper membranes to separate plasma and the volume of plasma that may be separated, it is indirectly measured by timing the movement of plasma along the length of a channel. The screening test for anemia relies upon measuring the time for fluid to propagate to two different areas of a paper-based device. This assay is able to easily and automatically differentiate blood samples with hematocrit levels ranging from 20% to 50%, thus successfully being able to discriminate between blood samples of anemic and non-anemic patients.
A novel RFID tag-sensor was designed and characterized using a paper-based microfluidic channel Subsequently, an optimized paper-based microfluidic assay for hematocrit measurement based on this channel was developed and integrated with the RFID tag.
In one embodiment, a straight channel paper microfluidic assay device was developed for integration with the RFID tag. In one embodiment, the channel included a 5 mm diameter sample port (S) where a specified volume of fluid is added. Contiguous to the sample port is a 20×2 mm hydrophilic channel (C) (
The paper-based microfluidic assay device is then used as a microstrip probe. The probe's impedance characteristics are significantly altered as the fluid propagates down the length of the channel The signal transduction concept by which the movement of the fluid is measured is discussed below.
In one embodiment, an RFID tag antenna design is integrated with the probe. The antenna's impedance is chosen such that as the fluid propagates down the probe, the flow manifests itself as a controlled drop in the backscatter signal strength of the tag. The probe-tag design and integration are discussed in more detail below. In one embodiment, both the probe and the tag were designed for use in the 902-928 MHz ISM band for UHF RFID operations as defined in North America. Other ISM bands may be used.
As seen in
The impedance ZAB, illustrated in
Z
AB
=f(εr) (1)
As fluid flows up the μ-PAD channel, illustrated by Δ in
ΔZ
AB
=f(Δεr) (2)
The flow of fluid in the paper channel is therefore converted to a change in the electrical characteristics (the impedance) of the probe structure. This change in impedance is related to a change in backscatter signal strength of a passive UHF RFID tag as discussed below.
The passive UHF RFID tag generally includes two components: an antenna and an integrated circuit (IC). The antenna serves as a portion of a transceiver and serves the dual purpose of scavenging power from the RFID reader to power the IC and for sending RFID tag ID information back to the RFID reader via modulated backscatter. The magnitude of the backscatter power received by the reader, PBS|reader, is given by:
P
BS|reader
=P
t(GtagGr)2(λ/4πd)4τ (3)
where Pt is the power transmitted by the reader antenna, Gr and Gtag are the reader and tag antenna gains, d is the separation between the reader and tag antennas, λ is the wavelength of the carrier and τ is a measure of the impedance match between the antenna and the terminal load connected to the antenna. τ is given by:
τ=(4RaRl)/(|Za+Zl|)2 (4)
where Ra and Rl are the effective resistance of the antenna and terminal load and Za and Zl are the impedance of the antenna and terminal load, respectively. Typically, the terminal load is the tag IC and thus Zl=Zc where Zc=Rc+jXc is the impedance of the tag IC.
In one embodiment of the design shown in
Z
l=(ZcZAB)/(Zc+ZAB) (5)
Relating equation 2 with equations 4 and 5, τ is also a function of the flow of fluid in the paper channel:
Δτ=(4RaRl)/(|Za+ΔZl|)2 (6)
From equation 6 and equation 3, the change in PBS reader can be computed as:
ΔPBS|reader=Pt(GtagGr)2(λ/4πd)4Δτ (7)
In one embodiment, the RFID antenna as shown in
The first step in the design process is therefore to determine εr loss tangent, tanδ, of the μ-PAD paper material in the dry and wet state. This is done by applying the μ-PAD paper material as a superstrate to a high-Q SIR (Stepped Impedance Resonator) filter (see
In the second step, the values of εr are used to simulate the change in ZAB. Referring to
Z
l\dry=(ZcZAB\dry)/(Zc+ZAB\dry) (8)
In one embodiment, an Alien Higgs 3 RFID IC (San José, Calif., USA) was used and has an experimentally determined value of Zc=18−164i at 915 MHz.
Using the table in
The backscatter signal change produced by wetting of the paper-based microfluidic device channel was evaluated for different fluids and different types of paper. To analyze the effect of different types of fluids in the device, 10 μL of distilled water (DIH2O), 1X phosphate buffer saline (1X PBS) and human plasma were added to the sample port, S (see
The ability of the RFID tag to track fluid flow in different types of materials was next measured. Commonly, lateral flow assays utilize nitrocellulose membrane, while paper-based flow-through assays, which are becoming more popular due to a lower cost of materials, employ Whatman 1 and Whatman 4 filtration papers. To select what materials might be used, the change in backscatter signal as plasma flowed up the hydrophilic channels created in these different materials was characterized. Each type of material demonstrated significant signal drop following wetting of the channel, indicating that each material is conducive to being used in devices for RFID tags (see
In order to use a timing assay using the RFID tag, it is important to characterize the change in the backscatter drop as fluid flowed up the probe. For this characterization, human plasma was added to the sample port of eight devices and the drop in signal as the fluid flowed in the channel under each 2 mm segment of the copper probe was measured. It was found that most of the backscatter signal drop occurred when fluid flowed underneath the first 8 mm of the copper probe, while only a small drop occurred over the last 2 mm of the probe (see
In order to measure the speed of flow of the plasma in the paper-based microfluidic assay, two separate areas of measurement on the assay were required. Utilizing the start and end points of the channel for measurements permitted the longest flow path and greatest differentiation of hematocrit values. In one embodiment, the paper-based device for hematocrit measurement was designed as an arch to permit two distinct areas of measurement along the linear 10 mm RFID tag probe (labeled as A1 and A2 in
The paper portion of this arched hematocrit assay device included a sample port, where a specified volume of blood is added, and a contiguous hydrophilic channel of varying thickness along its length (see
Following wax printing, 1.70 μL of plasma separation buffer was added to the center of the sample port of each assay and allowed to spread out radially to fill the sample port area. Assays were dried at 65° C. for 2 minutes and stored at room temperature until integrated with the RFID tag. The 10 mm probe of each antenna was aligned across the paper-based hematocrit assay as specified above. The first 3.5 mm of the tip of the probe overlapped with the channel as it exited the sample port area. This allowed plasma to be detected immediately after it is separated from blood and entered the curved channel The next 4.5 to 8 mm of the probe was placed over the end of the curved channel (see
Devices consisting of a paper-based assay and attached RFID tag were manufactured and tested using human blood (Innovative Research, Inc., Novi, Mich., USA). The initial measurement of hematocrit was performed by filling a capillary tube with blood and sealing one end with clay. The capillary tube was centrifuged at 10,500 RPM for 5 minutes using a ZIPocrit centrifuge (LW Scientific, Lawrenceville, Ga., USA). The percent hematocrit was estimated using a microhematocrit centrifuge. To create hematocrit samples from 20% to 50%, plasma was then either added to the blood (for lower hematocrit values) or removed from the blood (for higher hematocrit values).
The hematocrit sensors were placed at a distance of 35 cm from the RFID reader and the reader was programed to make four readings per second with a maximum transmit power of 36 dBm. Thirty seconds after RFID readings were initiated, 15 μL of whole blood were added to each device. The movement of plasma from the sample port down the channel was evaluated both visually and electronically. Visual analysis of the plasma flow time utilized the point at which the plasma passed completely under the first probe area (A1 in
To fine-tune the data and reduce the noise in the backscatter signal due to multipath and frequency hopping effects, the average backscatter signal value over every 2 seconds was determined.
The start time of plasma flow was determined to be the point at which stage 2 began. End times for plasma flow were calculated in two manners: (1) the beginning of S4 and (2) the beginning of S5. To initially test the efficacy of the device, blood samples with hematocrit levels from 20% to 50% were tested in quadruplicate and the average plasma flow times calculated. Using RFID enabled remote sensing, blood samples with hematocrit levels of 20, 30, 40 and 50 percent had flow times of 90, 149, 229 and >900 seconds (endpoint 1 measurements), respectively (see
In order for remote sensing utilizing RFID tags to be useful for time-based point-of-care assays, it is essential that the results from the RFID tag closely match the results achieved visually. Comparing the flow times achieved by these two different data acquisition methods for the hematocrit measurements, a linear relationship was determined (y=0.911x+15.3, R2=0.968) between visual measurements and RFID measurements made at endpoint 1 (see
Although the use of this device in measuring blood anomalies such as anemia has been discussed, it may be used to measure components of many fluids that can be separated by fluid flow.
Unless otherwise indicated, all numbers expressing lengths, widths, depths, or other dimensions, and so forth used in the specification and claims are to be understood in all instances as indicating both the exact values as shown and as being modified by the term “about.” Accordingly, unless indicated to the contrary, the numerical parameters set forth in the specification and attached claims are approximations that may vary depending upon the desired properties sought to be obtained. At the very least, and not as an attempt to limit the application of the doctrine of equivalents to the scope of the claims, each numerical parameter should at least be construed in light of the number of reported significant digits and by applying ordinary rounding techniques. Any specific value may vary by 20%.
The terms “a,” “an,” “the,” and similar referents used in the context of describing the invention (especially in the context of the following claims) are to be construed to cover both the singular and the plural, unless otherwise indicated herein or clearly contradicted by context. All methods described herein can be performed in any suitable order unless otherwise indicated herein or otherwise clearly contradicted by context. The use of any and all examples, or exemplary language (e.g., “such as”) provided herein is intended merely to better illuminate the invention and does not pose a limitation on the scope of any claim. No language in the specification should be construed as indicating any non-claimed element essential to the practice of the invention.
Groupings of alternative elements or embodiments disclosed herein are not to be construed as limitations. Each group member may be referred to and claimed individually or in any combination with other members of the group or other elements found herein. It is anticipated that one or more members of a group may be included in, or deleted from, a group for reasons of convenience and/or patentability. When any such inclusion or deletion occurs, the specification is deemed to contain the group as modified thus fulfilling the written description of all Markush groups used in the appended claims.
Certain embodiments are described herein, including the best mode known to the inventor for carrying out the spirit of the present disclosure. Of course, variations on these described embodiments will become apparent to those of ordinary skill in the art upon reading the foregoing description. The inventor expects skilled artisans to employ such variations as appropriate, and the inventor intends for the invention to be practiced otherwise than specifically described herein. Accordingly, the claims include all modifications and equivalents of the subject matter recited in the claims as permitted by applicable law. Moreover, any combination of the above-described elements in all possible variations thereof is contemplated unless otherwise indicated herein or otherwise clearly contradicted by context.
In closing, it is to be understood that the embodiments disclosed herein are illustrative of the principles of the claims. Other modifications that may be employed are within the scope of the claims. Thus, by way of example, but not of limitation, alternative embodiments may be utilized in accordance with the teachings herein. Accordingly, the claims are not limited to embodiments precisely as shown and described.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/US2017/027689 | 4/14/2017 | WO | 00 |
Number | Date | Country | |
---|---|---|---|
62322890 | Apr 2016 | US |